IB Delta Suite offers automated quantitative Delta T1 maps for measurement of brain tumor volumes in monitoring treatment response.
Product specifications Information source: Vendor
Last updated: July 31, 2020
General
Product name IB Delta Suite
Company Imaging Biometrics
Subspeciality Neuro
Modality MR
Disease targeted Neuro lesions
Key-features Image standardization, Delta T1 maps
Suggested use
Data characteristics
Population Neuro exams
Input T1-weighted, pre- and post-contrast images
Input format DICOM
Output Quantitative Delta T1 maps
Output format DICOM (RGB and monochrome)
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Hybrid solution, multiple channel partners
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time < 3 sec
Certification
CE Certified, Class I
FDA 510(k) cleared, Class II
Market presence
On market since 01-2013
Distribution channels Eureka Clinical AI, QMENTA, Blackford Analysis, Medimsight, CorTechs Labs, aycan Medical Systems, Pixmeo
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription, Traditional license (upfront payment plus annual maintenance)
Based on Number of users, Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance

  • Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network (read)

Non-peer reviewed papers on performance
Other relevant papers